« Back
Home /
c-Met inhibitor 1

c-Met inhibitor 1

Manufacturer	TargetMol
Category	Oncology By Cell Type Blastoma Carcinoma Glioma Hematology Lymphoma Myeloma Melanoma Sarcoma Adenocarcinoma Mesothelioma Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Format	Powder
Amount	100mg
Item no.	TMO-T10655-100mg
Targets	MET
CASRN	1357072-61-7
eClass 6.1	30220300
eClass 9.0	32160605
Available
Short Description	c-Met inhibitor 1 is a c-Met receptor signaling pathway inhibitor, used for the treatment of cancer including glioblastoma, gastric, and pancreatic cancer.
Shipping	cool pack
Storage	-20°
Molecular Weight	362, 41
Pathway	Tyrosine Kinase/Adaptors
Target	c-Met/HGFR

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100mg

available

Delivery expected until 5/16/2024